ATE520658T1 - Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE520658T1 ATE520658T1 AT08872697T AT08872697T ATE520658T1 AT E520658 T1 ATE520658 T1 AT E520658T1 AT 08872697 T AT08872697 T AT 08872697T AT 08872697 T AT08872697 T AT 08872697T AT E520658 T1 ATE520658 T1 AT E520658T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- new
- pharmaceutical compositions
- production process
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0708604A FR2924713B1 (fr) | 2007-12-11 | 2007-12-11 | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2008/001716 WO2009103875A1 (fr) | 2007-12-11 | 2008-12-10 | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE520658T1 true ATE520658T1 (de) | 2011-09-15 |
Family
ID=39158541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08872697T ATE520658T1 (de) | 2007-12-11 | 2008-12-10 | Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (26)
Country | Link |
---|---|
US (1) | US8288433B2 (de) |
EP (1) | EP2231598B1 (de) |
JP (1) | JP5247814B2 (de) |
KR (1) | KR20100083195A (de) |
CN (1) | CN101910128B (de) |
AR (1) | AR069643A1 (de) |
AT (1) | ATE520658T1 (de) |
AU (1) | AU2008351147B2 (de) |
BR (1) | BRPI0822066A2 (de) |
CA (1) | CA2707853C (de) |
DK (1) | DK2231598T3 (de) |
EA (1) | EA201000885A1 (de) |
ES (1) | ES2371699T3 (de) |
FR (1) | FR2924713B1 (de) |
GE (1) | GEP20135733B (de) |
HR (1) | HRP20110755T1 (de) |
MA (1) | MA31901B1 (de) |
MX (1) | MX2010006446A (de) |
MY (1) | MY147973A (de) |
NZ (1) | NZ586070A (de) |
PL (1) | PL2231598T3 (de) |
PT (1) | PT2231598E (de) |
RS (1) | RS52001B (de) |
SI (1) | SI2231598T1 (de) |
UA (1) | UA97035C2 (de) |
WO (1) | WO2009103875A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8354394B2 (en) * | 2009-10-29 | 2013-01-15 | Merck Sharp & Dohme Corp. | Diuretics |
CN102883610A (zh) | 2010-02-12 | 2013-01-16 | 默沙东公司 | 二醇二氮烯*环戊基衍生物 |
WO2011146371A1 (en) | 2010-05-21 | 2011-11-24 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
RU2013124814A (ru) | 2010-10-29 | 2014-12-10 | Мерк Шарп Энд Домэ Корп. | Гетероциклические производные диазенийдиолата |
JO3350B1 (ar) * | 2011-03-07 | 2019-03-13 | Merck Sharp & Dohme | مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات |
EP2704568B1 (de) | 2011-05-02 | 2018-01-24 | Merck Sharp & Dohme Corp. | Diazeniumdiolat-cyclohexyl-derivate |
CN109608371B (zh) * | 2019-01-16 | 2020-12-29 | 泰州学院 | O2-4-(3-(4-胺磺酰基苯基)脲)苯基偶氮鎓二醇盐衍生物、制备方法及用途 |
CN114805183B (zh) * | 2022-05-07 | 2022-12-27 | 武汉科技大学 | 一类no供体型荜茇酰胺衍生物、制备方法及用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1203691A (en) * | 1968-03-06 | 1970-09-03 | Science Union & Cie | New disubstituted n-amino indoline derivatives and process for preparing them |
JPH0233030B2 (ja) * | 1982-01-18 | 1990-07-25 | Mitsui Toatsu Chemicals | Surufuamoiruansokukosanjudotaioyobisoreojukoseibuntoshitefukumuchiryoyososeibutsu |
JPH07118231A (ja) * | 1993-10-22 | 1995-05-09 | Nippon Oil & Fats Co Ltd | スルファモイル安息香酸誘導体 |
US5958427A (en) * | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
AUPS236902A0 (en) * | 2002-05-16 | 2002-06-13 | Northern Sydney Area Health Service | Composition and method for treating hypertension |
CA2574535A1 (en) * | 2004-11-15 | 2006-05-26 | Nitromed, Inc. | Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
CA2597460A1 (en) * | 2005-02-24 | 2006-08-31 | Nitromed, Inc. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
AU2009206635A1 (en) * | 2008-01-24 | 2009-07-30 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
US8106034B2 (en) * | 2008-02-08 | 2012-01-31 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
-
2007
- 2007-12-11 FR FR0708604A patent/FR2924713B1/fr not_active Expired - Fee Related
-
2008
- 2008-12-10 ES ES08872697T patent/ES2371699T3/es active Active
- 2008-12-10 MX MX2010006446A patent/MX2010006446A/es active IP Right Grant
- 2008-12-10 AT AT08872697T patent/ATE520658T1/de active
- 2008-12-10 UA UAA201008615A patent/UA97035C2/ru unknown
- 2008-12-10 JP JP2010537487A patent/JP5247814B2/ja not_active Expired - Fee Related
- 2008-12-10 MY MYPI2010002633A patent/MY147973A/en unknown
- 2008-12-10 CA CA2707853A patent/CA2707853C/fr not_active Expired - Fee Related
- 2008-12-10 KR KR1020107012930A patent/KR20100083195A/ko active IP Right Grant
- 2008-12-10 PL PL08872697T patent/PL2231598T3/pl unknown
- 2008-12-10 DK DK08872697.1T patent/DK2231598T3/da active
- 2008-12-10 RS RS20110438A patent/RS52001B/en unknown
- 2008-12-10 EP EP08872697A patent/EP2231598B1/de active Active
- 2008-12-10 NZ NZ586070A patent/NZ586070A/en not_active IP Right Cessation
- 2008-12-10 WO PCT/FR2008/001716 patent/WO2009103875A1/fr active Application Filing
- 2008-12-10 SI SI200830404T patent/SI2231598T1/sl unknown
- 2008-12-10 AU AU2008351147A patent/AU2008351147B2/en not_active Ceased
- 2008-12-10 CN CN2008801229307A patent/CN101910128B/zh not_active Expired - Fee Related
- 2008-12-10 EA EA201000885A patent/EA201000885A1/ru unknown
- 2008-12-10 BR BRPI0822066A patent/BRPI0822066A2/pt not_active IP Right Cessation
- 2008-12-10 US US12/735,048 patent/US8288433B2/en not_active Expired - Fee Related
- 2008-12-10 GE GEAP200811874A patent/GEP20135733B/en unknown
- 2008-12-10 PT PT08872697T patent/PT2231598E/pt unknown
- 2008-12-11 AR ARP080105371A patent/AR069643A1/es not_active Application Discontinuation
-
2010
- 2010-06-07 MA MA32894A patent/MA31901B1/fr unknown
-
2011
- 2011-10-17 HR HR20110755T patent/HRP20110755T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US20100286225A1 (en) | 2010-11-11 |
EP2231598A1 (de) | 2010-09-29 |
AR069643A1 (es) | 2010-02-10 |
MA31901B1 (fr) | 2010-12-01 |
NZ586070A (en) | 2012-06-29 |
AU2008351147A1 (en) | 2009-08-27 |
UA97035C2 (ru) | 2011-12-26 |
MX2010006446A (es) | 2010-07-05 |
HRP20110755T1 (hr) | 2011-11-30 |
ES2371699T3 (es) | 2012-01-09 |
US8288433B2 (en) | 2012-10-16 |
SI2231598T1 (sl) | 2011-11-30 |
GEP20135733B (en) | 2013-01-25 |
BRPI0822066A2 (pt) | 2015-09-22 |
CN101910128A (zh) | 2010-12-08 |
CA2707853A1 (fr) | 2009-08-27 |
JP5247814B2 (ja) | 2013-07-24 |
AU2008351147B2 (en) | 2012-04-12 |
JP2011506408A (ja) | 2011-03-03 |
EP2231598B1 (de) | 2011-08-17 |
KR20100083195A (ko) | 2010-07-21 |
MY147973A (en) | 2013-02-28 |
PL2231598T3 (pl) | 2011-12-30 |
CA2707853C (fr) | 2013-02-05 |
CN101910128B (zh) | 2013-01-16 |
EA201000885A1 (ru) | 2011-02-28 |
RS52001B (en) | 2012-04-30 |
DK2231598T3 (da) | 2011-12-05 |
FR2924713A1 (fr) | 2009-06-12 |
PT2231598E (pt) | 2011-10-11 |
FR2924713B1 (fr) | 2010-01-29 |
WO2009103875A1 (fr) | 2009-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2140867I2 (lt) | Farmacinė kompozicija | |
EP2399910A4 (de) | Neue triazinderivate und pharmazeutische zusammensetzung, die diese enthält | |
IL192845A (en) | The history of benzamide and the trower, a process for making them and their pharmaceutical preparations | |
IL215065A (en) | Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
EP2191826A4 (de) | Pharmazeutische zusammensetzung | |
EP2157093A4 (de) | Heterocyclische pyrrolo-stickstoffhaltige derivate, deren herstellung und pharmazeutische verwendung | |
ATE520658T1 (de) | Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen | |
ATE542815T1 (de) | Kokristalle und pharmazeutische zusammensetzungen damit | |
ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
PL2036892T3 (pl) | Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
EP2116242A4 (de) | Neue pharmazeutische zusammensetzung | |
GB0709541D0 (en) | Pharmaceutical excipient | |
ATE440842T1 (de) | Neue trizyklische derivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen, die sie enthalten | |
GB2454567B (en) | Anti-malarial pharmaceutical composition | |
ATE530546T1 (de) | Kokristalle und pharmazeutische zusammensetzungen damit | |
ATE389398T1 (de) | Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen | |
IL212942A (en) | History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses | |
EP2292242A4 (de) | Scutellarinderivat, herstellungsverfahren dafür, pharmazeutische zusammensetzung und ihre verwendung | |
BRPI0819202A2 (pt) | Derivado heterocíclico, e, composição farmacêutica | |
EP2116241A4 (de) | Pharmazeutische zusammensetzung | |
EP2156832A4 (de) | Pharmazeutische zusammensetzung | |
ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
ATE437857T1 (de) | Neuartige pyridinylaminalkylen- und pyridinyloxalkylen-cyclopropanamine, herstellungsverfahren dafür und pharmazeutische zusammensetzungen damit | |
ATE481393T1 (de) | Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2231598 Country of ref document: EP |